Drug
abrocitinib
Marketed as CIBINQO.
Generic name
abrocitinib
Brand names
CIBINQO
First FDA approval
2022-01-14
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA213871 | CIBINQO | 2022-01-14 | PFIZER |
Manufacturers
PFIZER
Frequently asked questions
When was abrocitinib FDA approved?
Earliest FDA approval on record: 2022-01-14.
What brand names are sold as abrocitinib?
CIBINQO.
Sources
Appeal a abrocitinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com